| Dr Jessica Brooke Saeger, MD | |
|
3551 Roger Brooke Dr, Fort Sam Houston, TX 78234-4504 | |
| (210) 916-0439 | |
| Not Available |
| Full Name | Dr Jessica Brooke Saeger |
|---|---|
| Gender | Female |
| Speciality | Military Health Care Provider |
| Location | 3551 Roger Brooke Dr, Fort Sam Houston, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649708629 | NPI | - | NPPES |
| Entity Name | Lewis Gale Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902977705 PECOS PAC ID: 6507886231 Enrollment ID: O20051128000164 |
News Archive
New methods of studying the evolution of treatment resistance in head and neck cancer are being developed by researchers at the Johns Hopkins Kimmel Cancer Center.
By adding electronics and computation technology to a simple cane that has been around since ancient times, a team of researchers at Columbia Engineering have transformed it into a 21st century robotic device that can provide light-touch assistance in walking to the aged and others with impaired mobility.
A newly developed antifungal, isavuconazole, is as effective as an existing drug, voriconazole, against invasive mold disease in cancer patients with less adverse effects, according to phase 3 clinical data presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, an infectious disease meeting of the American Society for Microbiology.
Scientists from VTT Technical Research Centre of Finland in collaboration with the University of Eastern Finland have recently discovered a serum biochemical signature which predicts progression to Alzheimer's disease months or even years before the first symptoms of the disease occur. The goal of the new collaboration between VTT and GE Healthcare is to validate this biomarker in a large patient cohort as well as to discover novel biomarker candidates.
The brain is an extremely adaptable organ - but it is also quite conservative. That's in short, what scientists from the Max Planck Institute of Neurobiology in Martinsried and their colleagues from the Friedrich Miescher Institute in Basel and the Ruhr-Universit-t Bochum were now able to show.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jessica Brooke Saeger, MD Urology Residency Residency Program, 3551 Roger Brooke Dr, Jbsa, Fort Sam Houston, TX 78234 Ph: (210) 916-4126 | Dr Jessica Brooke Saeger, MD 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234-4504 Ph: (210) 916-0439 |
News Archive
New methods of studying the evolution of treatment resistance in head and neck cancer are being developed by researchers at the Johns Hopkins Kimmel Cancer Center.
By adding electronics and computation technology to a simple cane that has been around since ancient times, a team of researchers at Columbia Engineering have transformed it into a 21st century robotic device that can provide light-touch assistance in walking to the aged and others with impaired mobility.
A newly developed antifungal, isavuconazole, is as effective as an existing drug, voriconazole, against invasive mold disease in cancer patients with less adverse effects, according to phase 3 clinical data presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, an infectious disease meeting of the American Society for Microbiology.
Scientists from VTT Technical Research Centre of Finland in collaboration with the University of Eastern Finland have recently discovered a serum biochemical signature which predicts progression to Alzheimer's disease months or even years before the first symptoms of the disease occur. The goal of the new collaboration between VTT and GE Healthcare is to validate this biomarker in a large patient cohort as well as to discover novel biomarker candidates.
The brain is an extremely adaptable organ - but it is also quite conservative. That's in short, what scientists from the Max Planck Institute of Neurobiology in Martinsried and their colleagues from the Friedrich Miescher Institute in Basel and the Ruhr-Universit-t Bochum were now able to show.
› Verified 6 days ago